HI PURE
DEAD

Serial Number

87619912

Owner

Pfanstiehl, Inc.

Attorney

Paul C. Llewellyn

Filing Date

Sep 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

HI PURE Trademark

Serial Number: 87619912

HI PURE is a trademark filed by Pfanstiehl, Inc. on September 23, 2017. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Pfanstiehl, Inc. (32 trademarks)

Waukegan, IL 60085

Entity Type: 03

Trademark Details

Filing Date

September 23, 2017

Registration Date

Not Registered

Goods & Services

Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry

Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 25, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 25, 2018 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 22, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 22, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 29, 2017 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2017 NWOS
NEW APPLICATION ENTERED
Sep 27, 2017 NWAP